A study identifies a potential drug target for triple negative breast cancer
Researchers led by Professor Zhang (US) have reported that BBOX1 is a potential therapeutic target in triple negative breast cancer. Effective BBOX1 inhibitors for the
Input your search keywords and press Enter.